News
MUDr. Libor Dvořáček: Microinvasiveness of surgery involves not only the method but also targeted solutions to varicose vein sources
Varicose veins, or chronic venous insufficiency of the lower extremities, are primarily a health issue, not purely a cosmetic one. This is because they are associated with the risk of complications that necessitate long-term therapy and complex treatment of these issues. As MUDr. Libor Dvořáček, the head physician of the Vasmedic Clinic, mentions in our brief interview on this topic, the approach of health insurance companies and the Ministry of Health has fortunately been changing in favor of day surgery – that is, microinvasive and much…
MUDr. Petr Majtan: Venofarmaka should receive at least partial coverage for hemorrhoidal disease − their benefit in this indication is clear
What is the use of venofarmaka before and after surgery for chronic venous disease (CVD), and what…
Wound Healing and Exudate – A Comprehensive Look at Moisture Management in Wounds
Exudate produced during the inflammatory phase of healing is a crucial factor that ensures a moist…
Effective antiosteoporotics from the aminobisphosphonate group can finally be prescribed by general practitioners from January 2024
Osteoporosis represents a serious societal problem generating numerous health and social…
Augmentation of Clozapine with Lurasidone in Resistant Schizophrenia in Real Practice
Treatment-resistant schizophrenia remains a clinical and pharmacological challenge. Clozapine…
Criteria for Progression in Fibrotic Non-IPF Interstitial Lung Disease
Fibrotic interstitial lung disease (fILD) is a challenging condition to manage with limited…
Selecting from the Red Book CHS: What's New in This Year's Recommendations for the Diagnosis and Treatment of CLL?
Chronic lymphocytic leukemia (CLL) is the most common lymphoid malignancy in adults in Europe and…
Lung screening in the Czech Republic has detected over a hundred cases of lung cancer
The purpose of lung screening, which has been ongoing in the Czech Republic since January 2022, is…
Safety of Tofacitinib in Ulcerative Colitis – Combined Results of 6 Studies
At the annual meeting of the American Gastroenterological Association (ACG) in October 2023 in…
Impact of Tofacitinib on the Quality of Life of Patients with Ulcerative Colitis
Tofacitinib is an oral Janus kinase (JAK) inhibitor used in the treatment of certain rheumatic…